NCT00141063View on ClinicalTrials.gov

Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD

PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 30, 2005

Study Completion Date

August 31, 2005

Conditions
ADHD
Interventions
DRUG

Focalin XR

Trial Locations (1)

89128

Center for Psychiatry & Behavioral Medicine, Las Vegas

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00141063 - Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD | Biotech Hunter | Biotech Hunter